Fighting cancer is more efficient at dawn, study finds

byUniversity of GenevaCredit: Unsplash/CC0 Public DomainThe ability of tumors to take hold and grow depends, among other things, on the effectiveness of the immune system in fighting them. Cance

Updated on: January 23,2024

Fighting cancer is more efficient at dawn, study finds

byUniversity of GenevaCredit: Unsplash/CC0 Public DomainThe ability of tumors to take hold and grow depends, among other things, on the effectiveness of the immune system in fighting them. Cance

Updated on:January 23,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on: April 20,2024

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Updated on:April 20,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on: January 29,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on:January 29,2024

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs

Updated on: March 25,2024

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs

Updated on:March 25,2024

Researchers discover pathway critical for lymphoma development

by H. Lee Moffitt Cancer Center & Research InstituteActivation of the polyamine-hypusine circuit is a hallmark of human cancer and of MYC-driven lymphoma. A, Copy number alterations (CNA) of

Updated on: February 20,2024

Researchers discover pathway critical for lymphoma development

by H. Lee Moffitt Cancer Center & Research InstituteActivation of the polyamine-hypusine circuit is a hallmark of human cancer and of MYC-driven lymphoma. A, Copy number alterations (CNA) of

Updated on:February 20,2024

New method to detect cancer cells faster, potentially improving outcomes

by Purdue UniversityA Purdue University team developed a method to screen one-bead-one-compound libraries against biological targets such as proteins or antibodies. Credit: Purdue UniversityThe d

Updated on: May 20,2024

New method to detect cancer cells faster, potentially improving outcomes

by Purdue UniversityA Purdue University team developed a method to screen one-bead-one-compound libraries against biological targets such as proteins or antibodies. Credit: Purdue UniversityThe d

Updated on:May 20,2024

Anal cancer rates and mortality have risen dramatically among Americans: study

by University of Texas Health Science Center at HoustonRates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have in

Updated on: June 28,2024

Anal cancer rates and mortality have risen dramatically among Americans: study

by University of Texas Health Science Center at HoustonRates of new anal cancer diagnoses and deaths related to human papillomavirus (HPV), the most common sexually transmitted infection, have in

Updated on:June 28,2024

Liquid biopsy chip detects tumor cells in 100 percent of blood samples from breast cancer patients

by Michael W. Dorsey,Worcester Polytechnic InstituteA circulating cancer cell (pink) attaches to carbon nanotube surface; white blood cells (blue) do not adhere and are later washed away. Credit

Updated on: May 23,2024

Liquid biopsy chip detects tumor cells in 100 percent of blood samples from breast cancer patients

by Michael W. Dorsey,Worcester Polytechnic InstituteA circulating cancer cell (pink) attaches to carbon nanotube surface; white blood cells (blue) do not adhere and are later washed away. Credit

Updated on:May 23,2024

Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

by Greg Glasgow,CU Anschutz Medical CampusCredit: CC0 Public DomainThe results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer

Updated on: March 30,2024

Clinical trial shows rucaparib extends progression-free survival for uterine cancer patients

by Greg Glasgow,CU Anschutz Medical CampusCredit: CC0 Public DomainThe results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer

Updated on:March 30,2024

US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainThe risk of hepatocellular carcinoma (HCC) in individuals of Mexican descent living in Los Angeles has increased with each succ

Updated on: January 02,2024

US residents of Mexican descent may have a higher risk of liver cancer with each successive generation

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainThe risk of hepatocellular carcinoma (HCC) in individuals of Mexican descent living in Los Angeles has increased with each succ

Updated on:January 02,2024

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n

Updated on: January 15,2024

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n

Updated on:January 15,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on: September 27,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on:September 27,2024